This webinar introduces key updates in acute ischemic stroke management, focusing on how modern decision‑making integrates time‑sensitive evaluation, advanced imaging, and AI‑supported tools. It also reviews the expanded…
Pompe disease is a rare, life-threatening genetic disorder caused by GAA enzyme deficiency, leading to glycogen buildup and muscle cell destruction. It presents on a spectrum, from infantile-onset…
NEW YORK (Reuters Health) – With the introduction of more intensive medical therapy, revascularization for asymptomatic carotid stenosis is likely to benefit less than 5% of patients, according…
NEW YORK (Reuters Health) – Alteplase can improve stroke outcomes even when it is not given until 3 to 4.5 hours after the stroke began, according to a…
NEW YORK (Reuters Health) – Findings from a new study suggest that contrary to what some researchers have hypothesized, migraine is not associated with atherosclerosis, but it may…
NEW YORK (Reuters Health) – In a postmortem study of patients with Alzheimer’s disease, diabetic subjects treated with both insulin and oral hypoglycemic agents had lower neuritic plaque…
NEW YORK (Reuters Health) – Patients with marked clinical fluctuation in neurologic status due to cerebral ischemia may benefit from thrombolytic therapy, researchers from Canada report in the…
Dr. Stephen Lane, DVM, explains Syringomyelia, a painful, neurological disease in canines that also has a counterpart in humans. References and Resources Heiss, J., et al. Elucidating the…
Among children presenting to the emergency department with headache, certain clinical characteristics might help identify those with headaches that are secondary to a life-threatening condition, according to recently…
In a recent study, diabetics who took both insulin and other medications for the disease had fewer plaques associated with Alzheimer’s disease than other patients. References and Resources…
Myriad Genetics, Inc. is discontinuing development of tarenflurbil, also known as Flurizan, after the investigational treatment for Alzheimer’s disease failed to achieve significance on the co-primary endpoints –…
Rasagiline 1 mg tablets slow the progression of Parkinson’s disease, according to Phase III trial data. From our partners at VerusMed VerusMed.com Sponsored by The Doctor’s Channel
